FFA-Induced Hypertension and Endothelial Dysfunction

NACompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

April 30, 2008

Study Completion Date

August 31, 2008

Conditions
Endothelial DysfunctionHypertension
Interventions
DRUG

Intralipid 20% @ 20cc/hour

In this arm subjects received Intralipid 20% Intravenous IV continuous infusion at 20cc/hour for 8 hours. The 20% intralipid solution is a long-chain triglyceride emulsion composed of 50% polyunsaturated fatty acids, 26% monounsaturated fatty acids, and 19% saturated fatty acids. During the intralipid infusion studies, subjects remained fasting

DRUG

Intralipid 20%@ 40cc/hour

In this arm subjects received Intralipid 20% IV continuous infusion at 40cc/hour for 8 hours. In this arm subjects will receive Intralipid 20% Intravenous IV continuous infusion at 20cc/hour for 8 hours. The 20% intralipid solution is a long-chain triglyceride emulsion composed of 50% polyunsaturated fatty acids, 26% monounsaturated fatty acids, and 19% saturated fatty acids. During the intralipid infusion studies, subjects remained fasting.

DRUG

Normal Saline

In this arm subjects received 0.9% Normal Saline continuous IV infusion at 40/cc for 8 hours.

DIETARY_SUPPLEMENT

32-gram oral fat load

In this arm subjects received oral liquid fat load prepared by the General Clinical Research Center (GCRC) at baseline and every 2 hours for 6 hours. Participants received fat with Free Fatty Acids (FFA) composed of 33% polyunsaturated fatty acids, 34% monounsaturated fatty acids, and 22% saturated fatty acids. The oral fat load in either low or high dose was given in four equally divided doses at 0, 2, 4, and 6 h.

DIETARY_SUPPLEMENT

64-gram oral fat load

In this arm subjects received 60-gram oral fat load intake at baseline and every 2 hours for 6 hours prepared by the General Clinical Research Center (GCRC). Participants received fat with Free Fatty Acids (FFA) composed of 33% polyunsaturated fatty acids, 34% monounsaturated fatty acids, and 22% saturated fatty acids. The oral fat load in either low or high dose was given in four equally divided doses at 0, 2, 4, and 6 h.

Trial Locations (1)

30303

Grady Memorial Hospital, Atlanta

All Listed Sponsors
collaborator

American Heart Association

OTHER

lead

Emory University

OTHER

NCT00589888 - FFA-Induced Hypertension and Endothelial Dysfunction | Biotech Hunter | Biotech Hunter